
Professor David Schaffer selected to serve as next director of QB3-Berkeley
July 07, 2020
Professor David Schaffer has been selected to serve as the next director of Berkeley’s California Institute for Quantitative Biosciences (QB3-Berkeley)
July 07, 2020
Professor David Schaffer has been selected to serve as the next director of Berkeley’s California Institute for Quantitative Biosciences (QB3-Berkeley)
July 07, 2020
In early March, YourChoice Therapeutics CEO Akash Bakshi was typing out his investor update when he tucked in a question at the bottom. His company’s progress toward using niclosamide, a medication normally used to treat tapeworms, as a new kind of birth control that stopped sperm from moving was going well — the startup had…
June 30, 2020
Scientists from Jennifer Doudna’s Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly opened up a pop-up COVID-19 testing laboratory in March, are now testing a quicker and cost-efficient way to obtain patient samples through saliva.
June 29, 2020
UC Berkeley scientists join newly formed N95DECON team, a group of more than 100 scientists from 10+ institutions, whose aim is to share data-driven information about N95 respirator decontamination.
June 25, 2020
A new research by UC Berkeley engineers, including Sanjay Kumar a professor of bioengineering and chemical and biomolecular engineering, has shed light on how tumor cells adhere to and move through brain tissue.
June 25, 2020
UC Berkeley researchers, including QB3-Berkeley faculty Teresa Head-Gordon and Jennifer Listgarten, win funding from the C3.ai Digital Transformation Institute to reduce the spread of COVID-19 and other emerging diseases.
June 25, 2020
Paul Alivisatos, Samsung Distinguished Professor of Nanoscience and Nanotechnology and UC Berkeley professor of Chemistry and Materials Science & Engineering, has been awarded the 2021 Priestley Medal.
Notifications